AzTrials
AzTrials

Dental ImplantationPhase 2NCT00066014

Clinical Investigation of Mandibular Implant Overdenture

A Phase 2 study testing Implant Overdenture Treatment in people with Dental Implantation, run by Virginia Commonwealth University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to compare the effectiveness of three variable dental implant attachment methodologies in conjunction with lower dental-implant retained/supported complete overdenture treatment. Read more about this study

Who is it for?
Ages 21 years and older
Conditions the study is for
Dental Implantation
What is being tested?
Implant Overdenture Treatment
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteUnited States
Study dates
Nov 1998to Jan 2007
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patient;
  • Male or female;
  • At least one year of previous conventional complete denture treatment history;
  • Willing to accept the conditions of the study and informed consent freely given;
  • Ability to participate for 6 years;
  • Able to understand and respond to self-reporting measurement scales used in the study;
Show all 9Show fewer
  • Minimum 20-mm interarch distance at the estimated vertical dimension of occlusion;
  • Adequate bone quality;
  • Adequate bone quantity to accommodate minimally four 3.75-mm diameter by 7-mm long Brånemark implants.

Who cannot join

  • Administrative or physical considerations which would seriously affect the surgical procedure or construe a hindrance for a six-year involvement;
  • History of drug or alcohol abuse;
  • Excessive smoking (1+ pack/day);
  • Uncontrolled systemic disease;
  • Inability to undergo minor oral surgery because of health or personal reasons;
  • Irradiated surgical site;
Show all 12Show fewer
  • Unrealistic expectations of the prosthodontic treatment outcome;
  • Psychological or psychiatric conditions that could influence the subject's reaction to treatment;
  • Acute or chronic TMD problems;
  • pregnancy;
  • Class II jaw relationship;
  • Conventional dental treatment the treatment of choice.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Virginia Commonwealth University

    Richmond, Virginia, 23298

Other trials in United States

About this study

The purpose of this study is to compare the effectiveness of three variable dental implant attachment methodologies in conjunction with lower dental-implant retained/supported complete overdenture treatment. These three methods are all presently used by dental practitioners, but vary significantly in terms of added treatment cost and complexity. The study tests the hypothesis that the least complex and costly method provides an equivalent treatment outcome to other more complex and costly methods.

Read the detailed description

This project utilizes 30 subjects in a prospective, randomly assigned clinical study that uses a four-period, six sequence, three treatment crossover design to test the hypothesis that defined outcomes of variable implant overdenture treatments are equivalent. The project tests three overdenture treatment modalities, (1) four-implant, bar/clip-attached treatment, (2) two-implant, bar/clip-attached treatment, and (3) two-implant independently attached (O-ring) treatment. Each subject has four dental implants placed into the anterior mandible and new dentures are fabricated. After successful implant integration, subjects are randomly assigned to one of six sequences of treatment. Each treatment is followed for data collection for at least twelve months before the mandibular denture is modified to incorporate the next treatment in the sequence. Equivalence is measured in terms of prosthesis retention, stability, supporting and peri-implant tissue response, patient satisfaction/preference and treatment complications/failures.

Information from this study will assist dental practitioners during treatment planning in selecting appropriate and cost effective treatment choices. There is an inverse relationship between edentulism in the U.S. population and socioeconomic status. If less costly and simplified treatment methods are shown to provide an equivalent treatment outcome to more costly/complex methods, these simplified treatments can be used to treat a larger percentage of the edentulous population.

Being tested
Implant Overdenture Treatment
Keywords
Dental Implantation-Osseointegrated, Dentures, Dental Prostheses, Denture, Implant-Supported

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Implant Overdenture TreatmentProcedure or surgery

    All overdenture treatment modalities were provided to each subject using a crossover design.

Study groups in NCT00066014
Study groupRoleWhat they receive
treatment modalities changed for comparisonActive comparatorAll subjects experienced all treatment modalities being studied.
Receives: Procedure: Implant Overdenture Treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparison of implant overdenture clinical modalities using clinical measures to compare treatment outcomes

    Measured: 6 month and 12 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2003 (estimated)
  2. Study startNov 1998
  3. Primary completionJan 2007
  4. Study completionJan 2007

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00066014
Sponsor's protocol ID
NIDCR-12204
Other IDs
R01DE012204
Status last verified
Jan 2010
First submitted
1 Aug 2003
Last updated
22 Feb 2012
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Implant Overdenture Treatment in people with Dental Implantation, run by Virginia Commonwealth University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Feb 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparison of implant overdenture clinical modalities using clinical measures to compare treatment outcomes (time frame: 6 month and 12 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Feb 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in